SynthesisPloS one2016

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Xin Mou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.